FB
BIO icon

Fulton Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fulton Bank’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-659
Closed -$216K – 642
2024
Q4 		$216K Sell
659
-11
-2% -$3.73K 0.01% 620
2024
Q3 		$224K Buy
+670
New +$213K 0.01% 611
2024
Q2 		– Sell
-702
Closed -$243K – 633
2024
Q1 		$243K Buy
+702
New +$231K 0.01% 550
2023
Q3 		– Sell
-559
Closed -$212K – 571
2023
Q2 		$212K Sell
559
-12
-2% -$4.88K 0.01% 522
2023
Q1 		$274K Buy
571
+76
+15% +$35.6K 0.01% 456
2022
Q4 		$208K Buy
495
+1
+0.2% +$404 0.01% 493
2022
Q3 		$206K Buy
494
+35
+8% +$17.4K 0.01% 454
2022
Q2 		$227K Sell
459
-16
-3% -$8.33K 0.01% 438
2022
Q1 		$267K Sell
475
-65
-12% -$39.2K 0.01% 439
2021
Q4 		$408K Buy
540
+10
+2% +$7.48K 0.02% 376
2021
Q3 		$396K Buy
530
+6
+1% +$4.5K 0.02% 358
2021
Q2 		$338K Buy
524
+10
+2% +$6.09K 0.02% 373
2021
Q1 		$293K Buy
514
+66
+15% +$39.1K 0.01% 383
2020
Q4 		$261K Buy
448
+28
+7% +$15.9K 0.01% 380
2020
Q3 		$217K Buy
+420
New +$213K 0.01% 398

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fulton Bank's BIO Position: Q1 2025 in Review

Fulton Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 659 shares — an estimated $216K sold.

Fulton Bank first reported a position in BIO in Q3 2020 and held it in 15 quarters. The position peaked at $408K in Q4 2021. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Fulton Bank reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Fulton Bank sold 659 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $216K.
  • Fulton Bank first reported a position in Bio-Rad Laboratories Class A in Q3 2020 and held it in 15 quarters.
  • Fulton Bank's Bio-Rad Laboratories Class A position peaked at $408K in Q4 2021.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Fulton Bank's 13F filing for Q1 2025, filed 9 Apr 2025.